Bojesen and Petersen Biotech has developed bActivate - a new product to aid diagnosis and efficient antimicrobial therapy of problem mares with chronic subclinical uterine infections. bActivate has been developed by two Danish researchers following their discovery that up to 10% of all mares may have subclinical uterine infections and the adverse impact of such infections on mare fertility. Veterinarians at the world’s largest equine hospital in Kentucky have demonstrated that bActivate virtually restored the live-foal rates to normal and thus re-vitalized mares that had been given up for breeding. If you are interested in the scientific data concerning bActivate, please visit our website.